BFA
ICPT

BlackRock Fund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

BlackRock Fund Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$60.9M Buy
560,812
+67,142
+14% +$8M 0.01% 1551
2016
Q3 		$81.3M Buy
493,670
+16,562
+3% +$2.61M 0.02% 1234
2016
Q2 		$68.1M Buy
477,108
+9,836
+2% +$1.43M 0.02% 1291
2016
Q1 		$60M Buy
467,272
+31,289
+7% +$3.69M 0.01% 1323
2015
Q4 		$65.1M Sell
435,983
-52,194
-11% -$8.84M 0.02% 1287
2015
Q3 		$81M Buy
488,177
+38,162
+8% +$8.39M 0.02% 1064
2015
Q2 		$109M Buy
450,015
+56,691
+14% +$15.1M 0.03% 926
2015
Q1 		$111M Buy
393,324
+48,982
+14% +$10.6M 0.03% 907
2014
Q4 		$53.7M Buy
344,342
+247,026
+254% +$45.6M 0.01% 1415
2014
Q3 		$23M Buy
97,316
+15,346
+19% +$3.91M 0.01% 1866
2014
Q2 		$19.4M Sell
81,970
-118,472
-59% -$31.2M 0.01% 2040
2014
Q1 		$66.1M Buy
200,442
+5,860
+3% +$1.98M 0.02% 1193
2013
Q4 		$13.3M Sell
194,582
-8,554
-4% -$494K ﹤0.01% 2211
2013
Q3 		$14M Buy
203,136
+46,452
+30% +$2.29M ﹤0.01% 2161
2013
Q2 		$7.03M Buy
+156,684
New +$5.35M ﹤0.01% 2483

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's ICPT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 14% in Q4 2016, buying an estimated $8M and bringing the position to 560,812 shares worth $60.9M. The position accounts for 0.01% of the portfolio, ranked #1551.

BlackRock Fund Advisors first reported a position in ICPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $111M in Q1 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • BlackRock Fund Advisors held 560,812 shares of Intercept Pharmaceuticals, Inc. worth $60.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 67,142 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $8M.
  • Intercept Pharmaceuticals, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1551 holding.
  • BlackRock Fund Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Intercept Pharmaceuticals, Inc. position peaked at $111M in Q1 2015.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.